This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Drug Names(s): Quilimmune-P
Description: Quilimmune-P is a vaccine designed to prevent Streptococcus pneumoniae infection in the elderly. Quilimmune-P consists of the conjugate vaccine in combination with QS-21, Antigenics' immune adjuvant designed to increase the body's immune response to a vaccine.
Additional information available to subscribers only: